Ferrol Hospital Complex (CHUF)
If you are the contact person for this centre and you wish to make any changes, please contact us.
SMC participants
Head of the Endocrinology and Nutrition Department at the Ferrol Hospital Complex (CHUF) and President of the Spanish Society for Obesity (SEEDO)
Contents related to this centre
Oral semaglutide is not effective in slowing the progression of the disease in patients with mild Alzheimer’s disease, according to the findings of the first large-scale, randomised phase 3 clinical trials published in The Lancet. In these trials, around 3,800 patients aged between 55 and 85 with a confirmed diagnosis and mild symptoms received up to 14 mg daily of oral semaglutide or a placebo. After two years, no significant difference in disease progression was observed.